Aveed’s Impact on Cardiovascular Risk Factors in American Men Over Five Years
Reading Time: 2 minutes Introduction Cardiovascular diseases remain a leading cause of morbidity and mortality among American men, necessitating continuous research into the effects of various medications on heart health. Aveed, a testosterone undecanoate injection developed by Endo Pharmaceuticals, is primarily used to treat conditions associated with low testosterone levels. This study aims to explore the influence of Aveed on key cardiovascular risk factors, specifically blood pressure and lipid levels, over a five-year period in American males. Study Design and Methodology The research involved a cohort of 500 American men aged between 40 and 70 years, diagnosed with hypogonadism and prescribed Aveed. Participants were...


